Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
Go back to Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance| Pfizer Inc. (NYSE: PFE) | Delayed: 27.46 -0.09 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.55 | 52 Week High | $37.39 | |||
| Open | $27.64 | 52 Week Low | $28.25 | |||
| Day High | $27.69 | P/E | 16.64 | |||
| Day Low | $27.36 | EPS | $1.65 | |||
| Volume | 26,041,615 | |||||

